Regeneron and other companies are working to develop ways to inject antibodies from recovered covid-19 patients into patients who are infected. Part of the research involves cloning antibodies from patients recovered in laboratories and using those clones as treatment.
Monoclonal antibodies, the hope of scientists
2020-05-07T22:06:03.262Z
Regeneron and other companies are working to develop ways to inject antibodies from recovered covid-19 patients into patients who are infected. Part of the research involves cloning ...